Elan Science One

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Sep 8, 2015	Proteostasis Therapeutics	$37.0M Series B	Bihua Chen	dRx Capital, F-Prime Capital, HealthCare Ventures, New Enterprise Associates, Rock Springs Capital, Sanofi Ventures

Total Raised

N/A

Valuation

N/A